Chromagen Company Profile
Chromagen is a leader in providing enabling detection technologies and powerful new assays for pharmacogenomics, new drug discovery, and life science research. The Company's integrated technology platform is one of the industry's most advanced systems, and provides solutions that help eliminate key bottlenecks in drug discovery and accelerate the development of new medicines.
Chromagen has addressed detection technology by linking several distinct disciplines in a systems approach. We have developed fluorescent dyes (now available with various active conjugation sites) and substrates; homogeneous assays for proteomic studies of enzymes; signal transduction pathways and biological receptors; sensitive heterogeneous assays employing proprietary nucleic acid capture chemistries for measuring gene expression; and proprietary fluorescence detection instrumentation which can detect multiple fluorescent endpoints simultaneously.
10441 Roselle Street, Suite A
United States of America
Drugs and Medications
ChromaGenâ¢ is a life changing aid for visual reading disorders often associated with dyslexia and an optical corrective solution for color deficiency (more commonly known as ...
Chromagen is a leader in providing enabling detection technologies and powerful new assays for pharmacogenomics, new drug discovery, and life science research. The Company's integrated technology plat...
More Information about "Chromagen" on BioPortfolio
We have published hundreds of Chromagen news stories on BioPortfolio along with dozens of Chromagen Clinical Trials and PubMed Articles about Chromagen for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Chromagen Companies in our database. You can also find out about relevant Chromagen Drugs and Medications on this site too.